Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 02, 2022

SELL
$8.58 - $17.65 $265 - $547
-31 Closed
0 $0
Q4 2021

Jan 25, 2022

SELL
$10.17 - $18.96 $11,807 - $22,012
-1,161 Reduced 97.4%
31 $1,000
Q3 2021

Oct 28, 2021

BUY
$11.67 - $18.07 $2,240 - $3,469
192 Added 19.2%
1,192 $14,000
Q2 2020

Jul 30, 2020

BUY
$27.86 - $35.93 $27,860 - $35,930
1,000 New
1,000 $29,000

Others Institutions Holding OYST

About Oyster Point Pharma, Inc.


  • Ticker OYST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,831,500
  • Description
  • Oyster Point Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical therapies to treat ophthalmic diseases in the United States. The company's product candidate is TYRVAYA, a nicotinic acetylcholine receptor agonist for the treatment of signs and symptoms of dry ...
More about OYST
Track This Portfolio

Track Signaturefd, LLC Portfolio

Follow Signaturefd, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signaturefd, LLC with notifications on news.